chr19-4896876-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001080523.3(ARRDC5):āc.254A>Gā(p.Asp85Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001080523.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARRDC5 | NM_001080523.3 | c.254A>G | p.Asp85Gly | missense_variant, splice_region_variant | 2/3 | ENST00000650722.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARRDC5 | ENST00000650722.2 | c.254A>G | p.Asp85Gly | missense_variant, splice_region_variant | 2/3 | NM_001080523.3 | P2 | ||
ARRDC5 | ENST00000381781.2 | c.296A>G | p.Asp99Gly | missense_variant, splice_region_variant | 2/3 | 3 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152006Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460264Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726562
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152006Hom.: 0 Cov.: 30 AF XY: 0.0000269 AC XY: 2AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.296A>G (p.D99G) alteration is located in exon 2 (coding exon 2) of the ARRDC5 gene. This alteration results from a A to G substitution at nucleotide position 296, causing the aspartic acid (D) at amino acid position 99 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at